NASDAQ:CBUS Cibus (CBUS) Stock Price, News & Analysis $3.36 +0.03 (+0.90%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$3.20 -0.17 (-4.91%) As of 05/30/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cibus Stock (NASDAQ:CBUS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cibus alerts:Sign Up Key Stats Today's Range$3.12▼$3.3850-Day Range$1.52▼$3.3652-Week Range$1.40▼$15.00Volume279,849 shsAverage Volume181,197 shsMarket Capitalization$109.78 millionP/E RatioN/ADividend YieldN/APrice Target$22.00Consensus RatingBuy Company OverviewCibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.Read More… Cibus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks40th Percentile Overall ScoreCBUS MarketRank™: Cibus scored higher than 40% of companies evaluated by MarketBeat, and ranked 111th out of 151 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingBuy Consensus RatingCibus has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageCibus has only been the subject of 2 research reports in the past 90 days.Read more about Cibus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Cibus are expected to decrease in the coming year, from ($2.96) to ($3.02) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cibus is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cibus is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCibus has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cibus' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.10% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 14.6, which indicates bearish sentiment.Change versus previous monthShort interest in Cibus has recently decreased by 2.11%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCibus does not currently pay a dividend.Dividend GrowthCibus does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted10.10% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 14.6, which indicates bearish sentiment.Change versus previous monthShort interest in Cibus has recently decreased by 2.11%, indicating that investor sentiment is improving. News and Social Media2.2 / 5News Sentiment0.97 News SentimentCibus has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cibus this week, compared to 3 articles on an average week.MarketBeat Follows1 people have added Cibus to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cibus insiders have not sold or bought any company stock.Percentage Held by Insiders31.16% of the stock of Cibus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.81% of the stock of Cibus is held by institutions.Read more about Cibus' insider trading history. Receive CBUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cibus and its competitors with MarketBeat's FREE daily newsletter. Email Address CBUS Stock News HeadlinesCibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside ChatMay 27, 2025 | globenewswire.comCibus at Alliance Global Partners: Strategic Gene Editing InsightsMay 23, 2025 | uk.investing.comEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.May 31, 2025 | Timothy Sykes (Ad)Cibus, Inc. to Present Advances in Gene-Editing Technology at AGP Annual Virtual Healthcare Company ShowcaseMay 21, 2025 | nasdaq.comCibus to Participate in Alliance Global Partner’s Annual Virtual Healthcare Company ShowcaseMay 20, 2025 | finance.yahoo.comCibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company ShowcaseMay 19, 2025 | globenewswire.comCibus, Inc. (CBUS) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comCibus, Inc. (NASDAQ:CBUS) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comSee More Headlines CBUS Stock Analysis - Frequently Asked Questions How have CBUS shares performed this year? Cibus' stock was trading at $2.78 on January 1st, 2025. Since then, CBUS stock has increased by 20.9% and is now trading at $3.36. View the best growth stocks for 2025 here. How were Cibus' earnings last quarter? Cibus, Inc. (NASDAQ:CBUS) announced its earnings results on Thursday, May, 8th. The company reported ($0.74) earnings per share for the quarter, missing the consensus estimate of ($0.70) by $0.04. The business had revenue of $1.03 million for the quarter, compared to analyst estimates of $1.15 million. Cibus had a negative trailing twelve-month return on equity of 28.17% and a negative net margin of 10,724.78%. When did Cibus IPO? Cibus (CBUS) raised $100 million in an initial public offering (IPO) on Thursday, February 14th 2019. The company issued 6,700,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray acted as the underwriters for the IPO. Who are Cibus' major shareholders? Top institutional shareholders of Cibus include Armistice Capital LLC (5.93%), Certior Financial Group LLC (0.45%), Charles Schwab Investment Management Inc. (0.17%) and Goldman Sachs Group Inc. (0.15%). Insiders that own company stock include Gregory Francis William Gocal, Carlo Broos and Gerhard Prante. View institutional ownership trends. How do I buy shares of Cibus? Shares of CBUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cibus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cibus investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), Visa (V), Netflix (nflx) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings5/08/2025Today5/31/2025Next Earnings (Estimated)8/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural chemicals Sub-IndustryChemicals Current SymbolNASDAQ:CBUS CIK1705843 Webwww.calyxt.com Phone(858) 450-0008FaxN/AEmployees48Year FoundedN/APrice Target and Rating Average Stock Price Target$22.00 High Stock Price Target$25.00 Low Stock Price Target$17.50 Potential Upside/Downside+554.8%Consensus RatingBuy Rating Score (0-4)3.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($10.98) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$267.64 million Net Margins-10,724.78% Pretax Margin-12,860.54% Return on Equity-28.17% Return on Assets-13.39% Debt Debt-to-Equity RatioN/A Current Ratio1.44 Quick Ratio1.44 Sales & Book Value Annual Sales$4.75 million Price / Sales23.11 Cash Flow$12.00 per share Price / Cash Flow0.28 Book Value$12.38 per share Price / Book0.27Miscellaneous Outstanding Shares32,672,000Free Float13,387,000Market Cap$109.78 million OptionableOptionable Beta1.70 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:CBUS) was last updated on 5/31/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cibus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.